Psychometric properties of WHODAS for use in patients with chikungunya in Brazil

Authors

DOI:

https://doi.org/10.1590/1809-2950/18036226042019

Keywords:

Chikungunya Fever, International Classification of Functioning, Disability and Health, Public Health, Physical Therapy Specialty

Abstract

The aim of this study is to validate an assessment tool for functioning and health according to the conceptual proposal of the International Classification of Functioning, Disability and Health (ICF), for its use in post-chikungunya patients. This is a validation study with individuals >17 years old of both sexes. Data collection was performed through interviews, gathering information on functioning (WHODAS), quality of life (WHOQOL-bref) and socio-demographic data. Statistical analysis used the Cronbach alpha coefficient (internal consistency) and Spearman correlation coefficient (convergent validation), means and standard deviations, with significance level of 5%. The sample consisted of 68 individuals. The mean values of scores were: 45.4 (±16.38) for WHODAS and 12.1 (±2.10) for WHOQOL-bref. The Cronbach’s alpha of the total value was α=0.93; all WHODAS domains presented values ≥0.75. The total value of WHODAS 2.0 had strong correlation with the physical domain (r=−0.74) and moderate correlation with the psychological (r=−0.68) and social (r=−0.42) domains of the WHOQOL-bref. The results indicate that WHODAS 2.0 is a valid instrument for the measurement of self-perceived functioning alteration in patients affected by chikungunya.

Downloads

Download data is not yet available.

References

Paul BJ, Sadanand S. Chikungunya infection: a re-emerging

epidemic. Rheumatol Ther. 2018;5(2):317-26. doi:10.1007/

s40744-018-0121-7

Azevedo RSS, Oliveira CS, Vasconcelos PFC. Chikungunya

risk for Brazil. Rev Saude Pública. 2015;49:58. doi:10.1590/

S0034-8910.2015049006219

Nunes MRT, Faria NR, Vasconcelos JM, Golding N, Kraemer

MUG, Oliveira LF, et al. Emergence and potential for spread

of Chikungunya virus in Brazil. BMC Med. 2015;13(1):102. doi:

https://doi.org/10.1186/s12916-015-0348-x

van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP.

Long-term sequelae of chikungunya virus disease: a systematic

review. Travel Med Infect Dis. 2017;15:8-22. doi: 10.1016/j.

tmaid.2017.01.004

Vijayan V, Sukumaran S. Chikungunya virus disease: an

emerging challenge for the rheumatologist. J Clin Rheumatol.

;22(4):203-11. doi: 10.1097/RHU.0000000000000396

Couturier E, Guillemin F, Mura M, Leon L, Virion JM, Letort MJ, et al.

Impaired quality of life after chikungunya virus infection: a 2-year

follow-up study. Rheumatology (Oxford). 2012;51(7):1315-22.

doi: 10.1093/rheumatology/kes015

Hossain MS, Hasan M, Islam MS, Islam S, Mozaffor M, Khan

MAS, et al. Chikungunya outbreak (2017) in Bangladesh: clinical

profile, economic impact and quality of life during the acute

phase of the disease. PLoS Negl Trop Dis. 2018;12(6): e0006561.

doi: 10.1371/journal.pntd.0006561

World Health Organization [Internet]. International classification

of functioning, disability and health (ICF). Genebra; 2003

[cited 2019 Sept 18]. Available from: https://www.who.int/

classifications/en/

Stucki G, Bickenbach J. Functioning: the third health indicator

in the health system and the key indicator for rehabilitation.

Eur J Phy Rehabil Med. 2017;53(1):134-8. doi: 10.23736/

S1973-9087.17.04565-8

Castro SS, Leite CF [Internet]. Avaliação de Saúde e Deficiência:

Manual do WHO Disability Assessment Schedule (WHODAS 2.0).

Uberaba: Organização Mundial da Saúde [cited 2019 Sept 18];

Available from: https://apps.who.int/iris/bitstream/hand

le/10665/43974/9788562599514_por.pdf;jsessionid=C14D1E0

FF1008AEDFE1E68D2B4DD?sequence=19

Brasil. Portaria nº 204, de 17 de fevereiro de 2016. Diário Oficial

da União [Internet]. 18 Fev. 2016 [cited 2019 Sept 18];1:23.

Available from: http://bvsms.saude.gov.br/bvs/saudelegis/

gm/2016/prt0204_17_02_2016.html

Castro SS, Leite CF. Translation and cross-cultural adaptation

of the World Health Organization Disability Assessment

Schedule – WHODAS 2.0. Fisioter Pesqui. 2017;24(4):385-91.

doi: 10.1590/1809-2950/17118724042017

Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S,

Vilagut G, et al. Validation of the “World Health Organization

Disability Assessment Schedule, WHODAS-2” in patients with

chronic diseases. Health Qual Life Outcomes. 2010;8:51. doi:

1186/1477-7525-8-51

Kutlay S, Küçükdeveci AA, Elhan AH, Oztuna D, Koç N, Tennant

A. Validation of the World Health Organization Disability

Assessment Schedule II (WHODAS-II) in patients with

osteoarthritis. Rheumatol Int. 2011;31(3):339-46. doi: 10.1007/

s00296-009-1306-8

Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, et al.

The clinimetric properties of the World Health Organization

Disability Assessment Schedule II in early inflammatory arthritis.

Arthritis Rheum. 2008;59(3):382-90. doi: 10.1002/art.23314

Meesters JJL, Verhoef J, Liem ISL, Putter H, Vliet Vlieland TP.

Validity and responsiveness of the World Health Organization

Disability Assessment Schedule II to assess disability in

rheumatoid arthritis patients. Rheumatology (Oxford).

;49(2):326-33. doi: 10.1093/rheumatology/kep369

Magistrale G, Pisani V, Argento O, Incerti CC, Bozzali M,

Cadavid D, et al. Validation of the World Health Organization

disability assessment schedule II (WHODAS-II) in patients

with multiple sclerosis. Mult Scler. 2015;21(4):448-56. doi:

1177/1352458514543732

Hudson M, Steele R, Taillefer S, Baron M, Canadian Scleroderma

Research Group. Quality of life in systemic sclerosis:

psychometric properties of the World Health Organization

Disability Assessment Schedule II. Arthritis Rheum.

;59(2):270-8. doi: 10.1002/art.23343

Cheung MK, Hung AT, Poon PK, Fong DY, Li LS, Chow ES,

et al. Validation of the World Health Organization Assessment

Schedule II Chinese traditional version (WHODAS II CT) in

persons with disabilities and chronic illnesses for Chinese

population. Disabil Rehabil. 2015;37(20):1902-7. doi:

3109/09638288.2014.989336

Park SH, Demetriou EA, Pepper KL, Song YJC, Thomas EE,

Hickie IB, et al. Validation of the 36-item and 12-item Self-Report

World Health Organization Disability Assessment Schedule II

(WHODAS-II) in individuals with autism spectrum disorder.

Autism Res. 2019;12(7)1101-11. doi: 10.1002/aur.2115

Ćwirlej-Sozańska A, Wilmowska-Pietruszyńska A, Sozański

B. Validation of the Polish version of the World Health

Organization Disability Assessment Schedule (WHODAS 2.0)

in an elderly population (60-70 years old). Int J Occup Saf

Ergon. 2018;24(3):386-94. doi: 10.1080/10803548.2017.1316596

Habtamu K, Alem A, Medhin G, Fekadu A, Dewey M, Prince M,

Hanlon C. Validation of the World Health Organization Disability

Assessment Schedule in people with severe mental disorders

in rural Ethiopia. Health Qual Life Outcomes. 2017;15(1):64. doi:

1186/s12955-017-0647-3

Küçükdeveci AA, Kutlay Ş, Yıldızlar D, Öztuna D, Elhan AH,

Tennant A. The reliability and validity of the World Health

Organization Disability Assessment Schedule (WHODASII) in stroke. Disabil Rehabil. 2013;35(3):214-20. doi:

3109/09638288.2012.690817

Chiu TY, Finger ME, Fellinghauer CS, Escorpizo R, Chi WC, Liou

T-H, et al. Validation of the World Health Organization Disability

Assessment Schedule 2.0 in adults with spinal cord injury in

Taiwan: a psychometric study. Spinal Cord. 2019;57(6):516-24.

doi:10.1038/s41393-018-0231-7

Barbosa KSS, Castro SS, Leite CF, Nacci FR, Accioly MF. Validation

the Brazilian version of World Health Organization Disability

Assessment Schedule 2.0 for people HIV/aids. Cienc Saude Coletiva.

:386. Available from: http://www.cienciaesaudecoletiva.com.

br/artigos/validacao-da-versao-brasileira-do-world-healthorganization-disability-assessment-schedule-20-em-individuoshivaids/16919?id=16919&id=16919

Castro SS, Leite CF, Baldin JE, Accioly MF. Validation of the Brazilian

version of WHODAS 2.0 in patients on hemodialysis therapy.

Fisioter Mov. 2018;31:e003130. doi: 10.1590/1980-5918.031.ao30

Skevington SM, Lotfy M, O’Connell KA, WHOQOL Group.

The World Health Organization’s WHOQOL-BREF quality

of life assessment: psychometric properties and results of

the international field trial. A report from the WHOQOL

group. Qual Life Res. 2004;13(2):299-310. doi: 10.1023/B:QU

RE.0000018486.91360.00

The World Health Organization quality of life assessment

(WHOQOL): development and general psychometric

properties. Soc Sci Med. 1998;46(12):1569-85.doi: 10.1016/

S0277-9536(98)00009-4

Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G,

Santos L, Pinzon V. Aplicação da versão em português do

instrumento abreviado de avaliação da qualidade de vida

“WHOQOL-bref”. Rev Saude Publica. 2000;34(2):178-83. doi:

1590/S0034-89102000000200012

Cronbach LJ. Coefficient alpha and the internal structure of tests.

Psychometrika. 1951;16(3):297-334. doi: 10.1007/BF02310555

Brito CAA, von Sohsten AKA, Leitão CCS, Brito RCCM, Azevedo

Valadares LD, Fonte CAM, et al. Pharmacologic management of

pain in patients with Chikungunya: a guideline. Rev Soc Bras Med

Trop. 2016;49(6):668-79. doi:10.1590/0037-8682-0279-2016

Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int

J Med Educ. 2011;2:53-5. doi: 10.5116/ijme.4dfb.8dfd

Chiu TY, Yen CF, Chou CH, Lin JD, Hwang AW, Liao HF, Chi WC.

Development of traditional Chinese version of World Health

Organization Disability Assessment Schedule 2.0 36-item

(WHODAS 2.0) in Taiwan: validity and reliability analyses. Res

Dev Disabil. 2014;35(11):2812-20. doi:10.1016/j.ridd.2014.07.009

Wolf AC, Tate RL, Lannin NA, Middleton J, Lane-Brown A,

Cameron ID. The World Health Organization Disability

Assessment Scale, WHODAS II: reliability and validity in the

measurement of activity and participation in a spinal cord

injury population. J Rehabil Med. 2012;44(9):747-55. doi:

2340/16501977-1016

Fisioter Pesqui. 2019;26(4):419-426

McKibbin C, Patterson TL, Jeste D V. Assessing disability in

older patients with schizophrenia results from the WHODAS-II.

J Nerv Ment Dis. 2004;192(6):405-13.doi: 10.1097/01.

nmd.0000130133.32276.83

Snell DL, Iverson GL, Panenka WJ, Silverberg N

Published

2019-08-07

Issue

Section

Original Research

How to Cite

Psychometric properties of WHODAS for use in patients with chikungunya in Brazil. (2019). Fisioterapia E Pesquisa, 26(4), 419-426. https://doi.org/10.1590/1809-2950/18036226042019